Skip to content

Meditation for Dementia Caregivers Major Depressive Disorder in Family Dementia Caregivers

Mentalizing Imagery Therapy for Major Depressive Disorder in Family Dementia Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02122068
Enrollment
26
Registered
2014-04-24
Start date
2014-04-30
Completion date
2015-09-30
Last updated
2021-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mentalizing Imagery Therapy, Relaxation Recording

Keywords

Meditation, Mindfulness, Caregiver, Dementia, Depression

Brief summary

Family dementia caregivers provide a needed service to relatives with dementia and to society, but are often at risk for consequences to their own health such as depression, reduced immune system function, and burnout. Mentalizing Imagery Therapy (MIT, previously known as Central Meditation and Imagery Therapy) is a novel group mindfulness and guided imagery intervention designed to help caregivers reduce depressive symptoms and cope with the stress of caregiving. We will conduct a pilot feasibility of MIT versus home relaxation practice with 24 dementia caregivers. Half of the caregivers will be randomly assigned to receive a relaxation recording, while the other half will receive MIT. To measure the effects of MIT, we will obtain depression symptom ratings and questionnaires about psychological symptoms before and after MIT. We will also study the biological effects of MIT. We will do so by measuring brain activity, recording the pulse in order to determine variation in beat to beat intervals of the heart, and studying patterns of gene expression.

Interventions

4 week long meditation and mindfulness intervention

BEHAVIORALRelaxation cd

Sponsors

Friends of Semel Institute
CollaboratorUNKNOWN
Morris A. Hazan Memorial Foundation
CollaboratorUNKNOWN
University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
45 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Caregivers of relatives with dementia who present to the UCLA Alzheimer and Dementia Care Program, or other UCLA geriatric or memory clinics for evaluation of dementia, cognitive impairment and/or co-existing behavioral disturbances. 2. Caregivers will be identified by the family member with dementia or the physician as the primary source of assistance and/or support 3. 45 years of age or older 4. Patient Health Questionnaire Score \> 9 5. In contact with the individual with dementia at least three times/week for no less than one year, and a relative of the care-recipient (i.e., spouse or adult child). 6. Adequate written and oral fluency in English to understand and complete study forms and converse with study personnel.

Exclusion criteria

* Current diagnosis of schizophrenia or any psychotic disorder including psychotic depression, mania, alcohol or drug dependence, mental retardation, any pervasive developmental disorder or cognitive disorder (according to DSM-IV) criteria. 2\. Medically unstable, delirious, or terminally ill (e.g. medical illness requiring hospitalization or intense outpatient management, such as heart disease; heart attack in the past 6 months; congestive heart failure; severe heart arrythmias; unstable hypertension; poorly controlled diabetes; or pending surgery). 3\. Past history of skull fracture; cranial surgery entering the calvarium; space occupying intracranial lesion; stroke/ aneurysm; Parkinson's or Huntington's disease; or Multiple Sclerosis. 4\. Participants regularly practicing (≥ 2 times per week) any of the techniques utilized in the study to reduce stress: meditation, guided imagery, yoga. 5\. Active suicidal plan, or suicide attempt within the past month. 6. Excessive use of alcohol, i.e., men whose alcohol consumption exceeds 14 standard drinks per week or 4 drinks per day, and women whose alcohol consumption exceeds 7 standard drinks per week or 3 drinks per day. 7\. Needing to adjust or change anti-depressant treatment, including medications, psychotherapy, repetitive Transcranial Magnetic Stimulation (rTMS), Electroconvulsive Therapy (ECT), or Vagus Nerve Stimulation (VNS). 8\. Ideas of harm toward the care recipient, current violence, or an APS report on file.

Design outcomes

Primary

MeasureTime frameDescription
Hamilton Depression Rating Scale1 week post intervention (5 weeks)17 item rating scale, range of scores 0-52, higher scores indicate worse outcome

Secondary

MeasureTime frameDescription
Quick Inventory of Depression Symptoms - Self Report1 week post intervention (5 weeks)16 item rating scale, range of scores 0-27, higher scores indicate worse outcome

Other

MeasureTime frameDescription
State Trait Anxiety Inventory1 week post intervention (5 weeks)20 item rating scale, scores range from 20 to 80, higher scores indicate worse outcome

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026